Alebund Pharmaceuticals Report issue

For profit Phase 2
Founded: Shanghai China (2018)

Organization Overview

First Clinical Trial
2020
NCT04551300
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Alebund Pharmaceuticals | Shanghai Alebund Pharmaceuticals Limited